Manufacturer
Exela Pharma Sciences,LLC
7 drugs, 8 product strengths, 12 recalls on record.
Drugs Exela Pharma Sciences,LLC makes
Sodium bicarbonateNo changeGeneric · 47 makersPharmacies pay from$0.38Unavailable6 open recallsTranexamic acid-1.6%Generic · 39 makersPharmacies pay from$24.882 open recallsCaffeine-0.1%Generic · 37 makersPharmacies pay from$2.49Verapamil+8.8%Generic · 31 makersPharmacies pay from$2.15Being discontinued3 open recallsCupric chlorideGeneric · 7 makersNo weekly pricePotassium acetateGeneric · 3 makersNo weekly priceZinc chlorideGeneric · 3 makersNo weekly price
Recalls
Class IIOngoingSep 17, 20254.2% Sodium Bicarbonate InjectionFailed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.Exela Pharma Sciences LLC · D-0620-2025Class IIOngoingApr 2, 20258.4% Sodium Bicarbonate InjectionLack of Assurance of SterilityExela Pharma Sciences LLC · D-0303-2025Class IOngoingNov 29, 20238.4% Sodium Bicarbonate InjectionPresence of Particulate Matter: SiliconeExela Pharma Sciences LLC · D-0116-2024Class IOngoingNov 29, 2023Midazolam in 0.8% Sodium Chloride Injection 100 mg/100 mLPresence of Particulate Matter: SiliconeExela Pharma Sciences LLC · D-0117-2024Class IOngoingNov 29, 2023ELCYS (cysteine hydrochloride injection)Presence of Particulate Matter: SiliconeExela Pharma Sciences LLC · D-0118-2024Class ITerminatedDec 21, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.Exela Pharma Sciences LLC · D-0079-2023Class ITerminatedDec 21, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.Exela Pharma Sciences LLC · D-0080-2023Class ITerminatedNov 2, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administrationExela Pharma Sciences LLC · D-0022-2023Class ITerminatedNov 2, 20228.4% Sodium Bicarbonate InjectionDefective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administrationExela Pharma Sciences LLC · D-0023-2023Class IITerminatedJan 19, 20228.4% Sodium Bicarbonate InjectionLack of Assurance of SterilityExela Pharma Sciences LLC · D-0369-2022Class IIITerminatedSep 23, 2020Potassium Acetate InjectionShort FillExela Pharma Sciences LLC · D-1585-2020Class IITerminatedMay 30, 2018Diclofenac Sodium and Misoprostol Delayed Release Tablets 75 mg/0.2 mgLabeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.Exela Pharma Sciences LLC · D-0826-2018
About Exela Pharma Sciences,LLC
No comments yet. Questions, tips, what worked for you - start the conversation.